An 82-year-old Caucasian woman with multiple comorbidities was undergoing endoscopic surveillance at our department for post-endoscopic curative resection of intramucosal adenocarcinoma of the gastric antrum. A follow-up upper endoscopy showed a superficial pyloric lesion (0-IIa+IIc, according to the Paris classification) located mainly in the bulbar segment and involving about 2/3 of the pylorus circumference. A narrow band imaging (Olympus ® ) study revealed loss of both crypts and vascular pattern (Fig. 1) . The multidisci- and epinephrine (1: 250,000). ENDO CUT Mode was used for mucosal incision, forced coagulation for submucosal dissection and soft coagulation for haemostasis. Due to lesion size and location, the retroflexion position was the main technical approach in the bulb (Fig. 2) , achieving complete and en block excision. In the subsequent artificial ulcer, comprising the whole circumference of the pylorus, it was possible to identify the entire pylorus muscle ring (Fig. 3 ). There were no complications. Histology revealed a moderately differentiated intramucosal adenocarcinoma that was fully excised (R0) with no lymphovascular invasion or ulceration. To minimize the risk of late pyloric stenosis, she empirically underwent oral corticosteroid therapy (30 mg of prednisolone per day), which was then tapered gradually (5 mg per week). The patient was discharged 48 h later without complaints. On endoscopic revaluation, 3 months later, no residual lesion or pyloric stenosis was documented (Fig. 4) .
ESD is currently recognized as the treatment of choice for resection of most gastric superficial neoplastic lesions defined as early gastric cancer (EGC) [1] . It allows high rates of curative resection with a good safety profile, preserving the stomach's integrity, allowing a better quality of life when compared to alternative therapies, even in potentially high-risk patients [2] . In the last 2 decades, with the development of ESD, a revolution in the treatment of EGC was achieved [1] . The possibility of en bloc endoscopic resection (94 and 95% reported in 2 single Portuguese centres), regardless of lesion size, has made ESD the favourite minimally invasive treatment for EGC [3, 4] . A recent systematic review documented a lower morbidity for ESD and a similar 5-year survival compared to surgery [5] .
However, therapies for lesions involving the pylorus are technically more difficult, resulting in a poorer outcome overall, considering rates of complete resection (58-79%), bleeding (8%), perforation (1%) and stenosis (1%), especially for larger lesion spreading over more than 50% of the pylorus circumference and for those with predominant duodenal expression [6] .
Metachronous gastric lesions are the main concern after a curative endoscopic resection, and the patients should be at regular endoscopic surveillance, probably every year and even more often than 5 years after ESD for EGC [4] .
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